DE3873007T2 - Kathartica. - Google Patents

Kathartica.

Info

Publication number
DE3873007T2
DE3873007T2 DE8888308842T DE3873007T DE3873007T2 DE 3873007 T2 DE3873007 T2 DE 3873007T2 DE 8888308842 T DE8888308842 T DE 8888308842T DE 3873007 T DE3873007 T DE 3873007T DE 3873007 T2 DE3873007 T2 DE 3873007T2
Authority
DE
Germany
Prior art keywords
effect
kathartica
catharic
cathartics
pgs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888308842T
Other languages
English (en)
Other versions
DE3873007D1 (de
Inventor
Ryuzo Ueno
Ryuji Ueno
Sachiko Kuno
Tomio Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of DE3873007D1 publication Critical patent/DE3873007D1/de
Application granted granted Critical
Publication of DE3873007T2 publication Critical patent/DE3873007T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Ceramic Products (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
DE8888308842T 1987-10-02 1988-09-23 Kathartica. Expired - Lifetime DE3873007T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25016387 1987-10-02

Publications (2)

Publication Number Publication Date
DE3873007D1 DE3873007D1 (de) 1992-08-27
DE3873007T2 true DE3873007T2 (de) 1992-12-03

Family

ID=17203760

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888308842T Expired - Lifetime DE3873007T2 (de) 1987-10-02 1988-09-23 Kathartica.

Country Status (12)

Country Link
EP (1) EP0310305B1 (de)
KR (1) KR930001833B1 (de)
AT (1) ATE78465T1 (de)
AU (1) AU609883B2 (de)
CA (1) CA1312014C (de)
DE (1) DE3873007T2 (de)
ES (1) ES2051862T3 (de)
GB (1) GB2210556B (de)
GR (1) GR3005681T3 (de)
NZ (1) NZ226362A (de)
OA (1) OA09016A (de)
ZA (1) ZA887260B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
EP0410646B1 (de) * 1989-07-27 1994-03-02 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen
DE69019431T2 (de) * 1989-07-27 1995-09-14 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
DE69018903T2 (de) * 1989-08-09 1995-08-24 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von Prostansäurederivaten zur Herstellung von Arzneimitteln zur Verbesserung der Ausscheidung von Nichtprotein in die Därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
CA2030344C (en) 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2039420C (en) * 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
EP1220849B1 (de) 1999-10-15 2004-05-19 Sucampo AG Bizyclische verbindungen zusammenstellung und verfahren zu ihrer stabilisierung
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
TWI324589B (en) * 2001-05-18 2010-05-11 Sucampo Ag Halogenated bioactive lipid compound
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
TWI263505B (en) 2001-11-19 2006-10-11 Sucampo Ag Pharmaceutical composition comprising a C1C-2 channel opener

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410720A (en) * 1973-08-06 1983-10-18 Hoffmann-La Roche Inc. 16-Fluoro prostaglandins
US4163016A (en) * 1977-07-05 1979-07-31 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
JPS5626830A (en) * 1979-08-10 1981-03-16 Kuraray Co Ltd Hydroformylation of lower olefin
US4374856A (en) * 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
GB2202468A (en) * 1987-03-25 1988-09-28 Smidth & Co As F L Cyclone
DE3869471D1 (de) * 1987-05-15 1992-04-30 Ueno Seiyaku Oyo Kenkyujo Kk Fiebersteigende zusammensetzung.
AU604156B2 (en) * 1988-09-14 1990-12-06 R-Tech Ueno, Ltd. Prostaglandins of the F series

Also Published As

Publication number Publication date
EP0310305A2 (de) 1989-04-05
KR930001833B1 (ko) 1993-03-15
GB8822455D0 (en) 1988-10-26
GB2210556A (en) 1989-06-14
NZ226362A (en) 1991-07-26
CA1312014C (en) 1992-12-29
EP0310305B1 (de) 1992-07-22
EP0310305A3 (en) 1989-06-14
GR3005681T3 (de) 1993-06-07
ZA887260B (en) 1989-06-28
ATE78465T1 (de) 1992-08-15
AU2292088A (en) 1989-04-06
AU609883B2 (en) 1991-05-09
KR890006241A (ko) 1989-06-12
GB2210556B (en) 1991-07-17
DE3873007D1 (de) 1992-08-27
ES2051862T3 (es) 1994-07-01
OA09016A (fr) 1991-03-31

Similar Documents

Publication Publication Date Title
DE3873007D1 (de) Kathartica.
FR2442849A1 (de)
FR2371449A1 (fr) Acide 1-carba-2-penem-3-carboxylique
FR2354338A1 (fr) Acides n-phosphonomethylene-monoaminoalcane-mono- et polyphosphoniques et acides n-phosphonomethylene-diaminoalcane-polyphosphoniques, et leur preparation
FR2372817A1 (fr) Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension
FR2387988A1 (fr) Esters de cefuroxime, leur preparation et leur application therapeutique
ES2028277T3 (es) Sintesis de zeolita l.
FR2422334A1 (de)
FR2367742A1 (fr) Derives d'a-thio-alcanoiques, leur preparation et leur utilisation
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
CA1262912C (en) TETRAHYDROFURANYLIC SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS
FR2389597A1 (de)
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2445838A1 (fr) Nouveaux 1a,3b-dihydroxy-5-steroides
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2433516A1 (fr) Pyridoxines, leur preparation et leurs utilisations therapeutiques
FR2377406A1 (fr) Composes de tetrathiapentalene et de tetraselenapentalene
FR2390435A1 (fr) Thiobenzylpyrimidines, leur preparation et leurs utilisations therapeutiques
FR2429202A1 (de)
FR2361393A1 (fr) (2-azabicyclo (2.2.2)octane-2-yl) diphenylalcanones et derives, leur preparation et leurs utilisations therapeutiques, notamment comme anti-diarrheiques
FR2400024A1 (fr) Nouveaux derives de penicilline
FR2361888A1 (fr) Aryloxy-amino-butanols, leur preparation et leurs utilisations therapeutiques
FR2400362A1 (fr) Medicaments a action anti-atherosmateuse a base de nouveaux derives de la pyridine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH